There were no significant differences (P > 0.05) between the NAFLD patients and normal controls with respect to gender, age, BMI, blood pressure, TC, high-density lipoprotein cholesterol, total bilirubin, direct bilirubin, γ-GT, GLU, or glycated albumin. The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.